 Jeffrey Glasheen
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitalists | 15 | 2022 | 266 | 2.770 |
Why?
| | Internal Medicine | 10 | 2016 | 280 | 1.700 |
Why?
| | Internship and Residency | 9 | 2022 | 1257 | 1.360 |
Why?
| | Hospital Medicine | 3 | 2022 | 92 | 1.210 |
Why?
| | Warfarin | 6 | 2011 | 170 | 1.150 |
Why?
| | Academic Medical Centers | 7 | 2017 | 547 | 1.110 |
Why?
| | Leadership | 3 | 2022 | 408 | 1.100 |
Why?
| | Quality Improvement | 6 | 2022 | 1289 | 1.000 |
Why?
| | Career Mobility | 2 | 2017 | 71 | 0.820 |
Why?
| | Anticoagulants | 5 | 2008 | 722 | 0.810 |
Why?
| | Ofloxacin | 4 | 2008 | 17 | 0.800 |
Why?
| | Levofloxacin | 4 | 2008 | 20 | 0.790 |
Why?
| | Education, Medical, Undergraduate | 2 | 2021 | 206 | 0.790 |
Why?
| | Models, Educational | 2 | 2015 | 89 | 0.700 |
Why?
| | Hospitalization | 5 | 2023 | 2433 | 0.670 |
Why?
| | Hospital Costs | 2 | 2011 | 124 | 0.650 |
Why?
| | Hemorrhage | 3 | 2008 | 809 | 0.510 |
Why?
| | Education, Medical | 3 | 2015 | 274 | 0.490 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2016 | 102 | 0.460 |
Why?
| | Mentors | 4 | 2022 | 219 | 0.460 |
Why?
| | Clinical Competence | 3 | 2015 | 1244 | 0.450 |
Why?
| | Stroke | 5 | 2015 | 1256 | 0.440 |
Why?
| | Patient Discharge | 5 | 2016 | 983 | 0.440 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2015 | 96 | 0.430 |
Why?
| | Medicaid | 2 | 2016 | 461 | 0.430 |
Why?
| | Patient Handoff | 1 | 2015 | 42 | 0.420 |
Why?
| | Efficiency | 2 | 2011 | 103 | 0.410 |
Why?
| | International Normalized Ratio | 4 | 2008 | 49 | 0.390 |
Why?
| | Faculty, Medical | 3 | 2016 | 302 | 0.370 |
Why?
| | Practice Patterns, Physicians' | 2 | 2011 | 1356 | 0.360 |
Why?
| | Perception | 1 | 2015 | 377 | 0.360 |
Why?
| | Hospitals | 2 | 2023 | 730 | 0.340 |
Why?
| | Job Satisfaction | 3 | 2022 | 240 | 0.330 |
Why?
| | Hospitals, University | 1 | 2011 | 176 | 0.330 |
Why?
| | Medicare | 3 | 2015 | 886 | 0.330 |
Why?
| | Polypharmacy | 1 | 2011 | 93 | 0.310 |
Why?
| | Humans | 44 | 2026 | 144759 | 0.310 |
Why?
| | Cooperative Behavior | 2 | 2011 | 465 | 0.310 |
Why?
| | Workload | 3 | 2026 | 170 | 0.300 |
Why?
| | Patient Readmission | 2 | 2013 | 758 | 0.300 |
Why?
| | Ischemic Attack, Transient | 1 | 2009 | 71 | 0.280 |
Why?
| | Inservice Training | 1 | 2009 | 117 | 0.280 |
Why?
| | Delivery of Health Care | 2 | 2021 | 947 | 0.270 |
Why?
| | Dysentery | 1 | 2007 | 1 | 0.270 |
Why?
| | Physicians | 2 | 2015 | 939 | 0.250 |
Why?
| | Curriculum | 5 | 2022 | 1059 | 0.250 |
Why?
| | Burnout, Professional | 3 | 2011 | 484 | 0.250 |
Why?
| | Anti-Bacterial Agents | 2 | 2008 | 1907 | 0.250 |
Why?
| | Ergonomics | 1 | 2026 | 29 | 0.240 |
Why?
| | Personnel Turnover | 1 | 2026 | 42 | 0.240 |
Why?
| | Patient Care Team | 1 | 2011 | 689 | 0.230 |
Why?
| | Career Choice | 2 | 2022 | 237 | 0.230 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2008 | 194 | 0.220 |
Why?
| | Drug Interactions | 4 | 2008 | 398 | 0.220 |
Why?
| | Acidosis, Lactic | 1 | 2005 | 45 | 0.220 |
Why?
| | Communication | 1 | 2011 | 965 | 0.210 |
Why?
| | Burkitt Lymphoma | 1 | 2005 | 62 | 0.210 |
Why?
| | Blood Pressure | 2 | 2009 | 1769 | 0.210 |
Why?
| | Feces | 1 | 2007 | 513 | 0.200 |
Why?
| | Length of Stay | 3 | 2016 | 1337 | 0.200 |
Why?
| | Antipsychotic Agents | 1 | 2025 | 213 | 0.200 |
Why?
| | Ambulatory Care Facilities | 1 | 2025 | 265 | 0.190 |
Why?
| | Hypercapnia | 1 | 2002 | 54 | 0.190 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 242 | 0.190 |
Why?
| | Stress, Psychological | 1 | 2011 | 1152 | 0.180 |
Why?
| | Hypothyroidism | 1 | 2002 | 67 | 0.180 |
Why?
| | Drug Monitoring | 1 | 2025 | 395 | 0.180 |
Why?
| | Academies and Institutes | 1 | 2022 | 60 | 0.180 |
Why?
| | Organizational Innovation | 2 | 2015 | 120 | 0.170 |
Why?
| | Primary Health Care | 1 | 2011 | 1733 | 0.170 |
Why?
| | Autism Spectrum Disorder | 1 | 2025 | 412 | 0.150 |
Why?
| | Hypoglycemia | 1 | 2005 | 477 | 0.150 |
Why?
| | Emergency Service, Hospital | 1 | 2011 | 2310 | 0.150 |
Why?
| | Risk Assessment | 1 | 2009 | 3671 | 0.150 |
Why?
| | Inpatients | 1 | 2023 | 545 | 0.150 |
Why?
| | Surveys and Questionnaires | 4 | 2026 | 6048 | 0.140 |
Why?
| | United States | 7 | 2016 | 15966 | 0.140 |
Why?
| | Fellowships and Scholarships | 1 | 2022 | 357 | 0.140 |
Why?
| | Program Evaluation | 1 | 2022 | 948 | 0.130 |
Why?
| | Hospital Mortality | 2 | 2021 | 1030 | 0.120 |
Why?
| | Insurance, Health | 2 | 2015 | 302 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5868 | 0.120 |
Why?
| | Uncompensated Care | 1 | 2015 | 20 | 0.120 |
Why?
| | Students | 1 | 2021 | 663 | 0.110 |
Why?
| | Medically Uninsured | 1 | 2015 | 129 | 0.110 |
Why?
| | Hospitals, Special | 1 | 2013 | 8 | 0.100 |
Why?
| | Retrospective Studies | 7 | 2021 | 17066 | 0.100 |
Why?
| | Mentoring | 1 | 2016 | 166 | 0.100 |
Why?
| | Pandemics | 1 | 2021 | 1694 | 0.090 |
Why?
| | Aged | 8 | 2015 | 25913 | 0.090 |
Why?
| | Female | 14 | 2025 | 78271 | 0.090 |
Why?
| | Male | 13 | 2025 | 72315 | 0.090 |
Why?
| | Evidence-Based Practice | 1 | 2013 | 238 | 0.080 |
Why?
| | Risk Factors | 5 | 2015 | 10779 | 0.080 |
Why?
| | Health Services for the Aged | 1 | 2011 | 70 | 0.080 |
Why?
| | Continuity of Patient Care | 1 | 2013 | 291 | 0.080 |
Why?
| | Specialties, Surgical | 1 | 2011 | 82 | 0.080 |
Why?
| | Time Factors | 2 | 2011 | 7173 | 0.080 |
Why?
| | Cerebral Hemorrhage | 1 | 2011 | 120 | 0.080 |
Why?
| | Patient Safety | 1 | 2013 | 347 | 0.070 |
Why?
| | Speech Disorders | 1 | 2009 | 29 | 0.070 |
Why?
| | Blood Cell Count | 1 | 2009 | 54 | 0.070 |
Why?
| | Tissue Plasminogen Activator | 1 | 2011 | 244 | 0.070 |
Why?
| | Data Collection | 1 | 2011 | 633 | 0.070 |
Why?
| | Personnel Staffing and Scheduling | 2 | 2007 | 98 | 0.070 |
Why?
| | Histamine H1 Antagonists | 1 | 2008 | 24 | 0.070 |
Why?
| | Diagnostic Tests, Routine | 1 | 2009 | 108 | 0.070 |
Why?
| | Adult | 7 | 2022 | 40449 | 0.070 |
Why?
| | Models, Organizational | 1 | 2008 | 144 | 0.070 |
Why?
| | Carotid Arteries | 1 | 2009 | 207 | 0.070 |
Why?
| | Neurology | 1 | 2009 | 112 | 0.070 |
Why?
| | Geriatrics | 1 | 2008 | 96 | 0.060 |
Why?
| | Benzodiazepines | 1 | 2008 | 167 | 0.060 |
Why?
| | Internet | 1 | 2011 | 699 | 0.060 |
Why?
| | Antidepressive Agents | 1 | 2008 | 248 | 0.060 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 634 | 0.060 |
Why?
| | Secondary Prevention | 1 | 2007 | 254 | 0.060 |
Why?
| | Hypnotics and Sedatives | 1 | 2008 | 216 | 0.060 |
Why?
| | Prazosin | 1 | 2005 | 25 | 0.060 |
Why?
| | Electrocardiography | 1 | 2009 | 662 | 0.060 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2005 | 42 | 0.060 |
Why?
| | Critical Care | 1 | 2011 | 695 | 0.060 |
Why?
| | Ultrasonography | 1 | 2009 | 770 | 0.050 |
Why?
| | Patient Selection | 1 | 2009 | 719 | 0.050 |
Why?
| | Azithromycin | 1 | 2005 | 104 | 0.050 |
Why?
| | Fatal Outcome | 1 | 2005 | 307 | 0.050 |
Why?
| | Lipids | 1 | 2009 | 710 | 0.050 |
Why?
| | Tumor Burden | 1 | 2005 | 319 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2115 | 0.050 |
Why?
| | Evidence-Based Medicine | 1 | 2007 | 732 | 0.050 |
Why?
| | Antihypertensive Agents | 1 | 2007 | 510 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2005 | 508 | 0.050 |
Why?
| | Thrombosis | 1 | 2007 | 393 | 0.050 |
Why?
| | Cohort Studies | 2 | 2021 | 5960 | 0.050 |
Why?
| | Atrial Fibrillation | 1 | 2009 | 550 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2005 | 289 | 0.050 |
Why?
| | Administration, Oral | 1 | 2005 | 847 | 0.050 |
Why?
| | Diagnostic Errors | 1 | 2023 | 175 | 0.050 |
Why?
| | Referral and Consultation | 1 | 2008 | 851 | 0.050 |
Why?
| | Prospective Studies | 3 | 2023 | 7990 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 405 | 0.040 |
Why?
| | Middle Aged | 4 | 2015 | 35875 | 0.040 |
Why?
| | Age Factors | 1 | 2009 | 3333 | 0.040 |
Why?
| | Feedback | 1 | 2022 | 181 | 0.040 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2005 | 497 | 0.040 |
Why?
| | Reference Values | 1 | 2002 | 797 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2007 | 1720 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2003 | 1047 | 0.040 |
Why?
| | Attitude of Health Personnel | 1 | 2007 | 1185 | 0.040 |
Why?
| | Hypertension | 1 | 2007 | 1263 | 0.030 |
Why?
| | Colorado | 3 | 2013 | 4564 | 0.030 |
Why?
| | Medicine | 1 | 2016 | 125 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2009 | 11679 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2021 | 1173 | 0.020 |
Why?
| | Education | 1 | 2013 | 104 | 0.020 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 248 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2013 | 221 | 0.020 |
Why?
| | Young Adult | 1 | 2008 | 14105 | 0.020 |
Why?
| | Medical Audit | 1 | 2011 | 77 | 0.020 |
Why?
| | Comprehension | 1 | 2013 | 180 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 200 | 0.020 |
Why?
| | Health Literacy | 1 | 2013 | 184 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11787 | 0.020 |
Why?
| | Self Care | 1 | 2013 | 389 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2013 | 901 | 0.020 |
Why?
| | Thrombolytic Therapy | 1 | 2011 | 163 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2013 | 8265 | 0.020 |
Why?
| | Self Efficacy | 1 | 2013 | 414 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2015 | 916 | 0.020 |
Why?
| | Sepsis | 1 | 2015 | 640 | 0.020 |
Why?
| | Training Support | 1 | 2008 | 36 | 0.020 |
Why?
| | Palliative Care | 1 | 2015 | 1002 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 22428 | 0.010 |
Why?
| | Work Schedule Tolerance | 1 | 2005 | 51 | 0.010 |
Why?
| | Child | 1 | 2025 | 22633 | 0.010 |
Why?
| | Quality of Health Care | 1 | 2005 | 691 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2005 | 2947 | 0.010 |
Why?
|
|
Glasheen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|